Medication info

Pharmaking Acyclovir Tablet 200 mg

Prescription medicationExpired
Ingredient · strength
Acyclovir›Strength being verified
Manufacturer / importer
Pharmaking Co., Ltd.
Appearance
Light blue round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 199401518 · Notified 1994.08.23

This product's status changed to Expired on 2023.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of herpes simplex; treatment of herpes zoster; treatment of chickenpox in children aged 2 years and older
Who uses it
Adults · Children
Adult dosage
1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. For severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; in recurrent cases, treatment should preferably begin at the onset of prodromal symptoms or when lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered 2 times daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2–3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6–12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. Patients with renal impairment are more susceptible to adverse neuropsychiatric reactions; use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of varicella-zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose 2 times daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10–25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Children's dosage
1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Children aged 2 years and older: Same as the adult dose. Children under 2 years: Administer 1/2 of the adult dose. There are not yet adequate data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of varicella in children aged 2 years and older: Administer 20 mg per ㎏ of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is more effective when started as soon as possible after the varicella rash appears; administer within 24 hours of rash onset if possible.

Ingredients

Manufacturer
Pharmaking Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex; treatment of herpes zoster; treatment of chickenpox in children aged 2 years and older

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infections of skin and mucous membranes
  • shingles virus infection
  • acute shingles pain
  • chickenpox
View approved original text

This medication is used to treat and prevent herpes virus infections of the skin and mucous membranes, including primary and recurrent genital herpes. It is also effective in treating shingles virus infections, especially in alleviating acute pain. However, its effectiveness for postherpetic neuralgia has not been clearly established. Additionally, it is used to treat chickenpox in children over 2 years of age. This medication effectively improves various symptoms caused by viral infections.

Dosage and Administration

Adult dosage

1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. For severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; in recurrent cases, treatment should preferably begin at the onset of prodromal symptoms or when lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered 2 times daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2–3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6–12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. Patients with renal impairment are more susceptible to adverse neuropsychiatric reactions; use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of varicella-zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose 2 times daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10–25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Children's dosage

1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Children aged 2 years and older: Same as the adult dose. Children under 2 years: Administer 1/2 of the adult dose. There are not yet adequate data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of varicella in children aged 2 years and older: Administer 20 mg per ㎏ of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is more effective when started as soon as possible after the varicella rash appears; administer within 24 hours of rash onset if possible.

Precautions

This medication should not be administered to patients who are hypersensitive to this medication, its components, or to valaciclovir. Caution should be exercised when administering to patients with decreased kidney function, as neuropsychiatric adverse reactions may occur more frequently. Patients with impaired liver function should be administered with caution due to the risk of further deterioration of liver function. In infants and children, the dosage should be minimal and given with special care. Elderly patients may have prolonged drug retention due to decreased renal function, hence the dosage and administration intervals should be adjusted with caution. Severe allergic reactions such as shock or anaphylaxis can rarely occur; if symptoms like decreased blood pressure or difficulty breathing are experienced, administration should be stopped immediately, and medical treatment should be sought. Hypersensitivity reactions such as skin rash, fever, vesicles, or urticaria may occur; if such symptoms appear, medication should be discontinued and a doctor consulted. Alopecia, dermatitis, severe skin reactions (Stevens-Johnson syndrome, Lyell syndrome) etc. can occur, so the skin condition should be closely monitored. Neuropsychiatric symptoms like confusion, drowsiness, hallucinations, and seizures can manifest, especially in elderly or kidney-impaired patients, warranting caution. Kidney function may be adversely affected; hence, it is important to regularly check urine status or conduct kidney-related tests. Blood-related abnormalities like leukopenia, bleeding, or anemia may occur; therefore, routine blood test results should be monitored. Liver function abnormalities or jaundice symptoms may emerge, thus liver function tests should be performed, and liver condition observed. Gastrointestinal symptoms such as nausea, vomiting, abdominal pain, or diarrhea may occur. If symptoms are severe, medication should be discontinued and a doctor consulted. Systemic symptoms like fever, muscle weakness, and headache may arise, hence one should closely monitor their physical condition. Symptoms such as myalgia or arthralgia may also occur. Cardiac rhythm irregularities or blood pressure changes may occur, so cardiovascular status should be monitored during administration. Difficulties in urination or urinary obstruction may occur; therefore, if encountering issues during urination, inform a doctor. Other symptoms reported include alopecia, sweating, visual disturbances, shortness of breath, so overall bodily changes should be closely monitored. If symptoms do not improve or worsen after 5 days of use for herpes simplex and chickenpox, or 7 days for shingles, alternative treatment methods should be considered. It is generally recommended to administer the medication as soon as symptoms occur, ideally within 5 days for shingles after skin symptoms appear, and within 3 days for chickenpox. In immunocompromised patients, intravenous administration should be considered. During the treatment period, particularly with high doses, adequate hydration is essential to prevent dehydration and reduce renal toxicity. In the treatment of recurrent genital herpes, careful consideration should be given whether to continue after more than 1 year of administration. Due to the risk of consciousness disturbance, caution should be exercised while driving or operating dangerous machinery, with additional caution for kidney-impaired patients. There may be drug interactions with this medication and other drugs, particularly those affecting kidney function, necessitating caution with co-administration. Pregnant women or those who might become pregnant should only use this medication when the benefits outweigh the risks to the fetus. The components of this medication are excreted in breast milk; therefore, ceasing breastfeeding during treatment is considered safe. Careful administration in infants and children is advised; especially in newborns or low birth weight infants, as safety has not been established and should only be used when necessary. Elderly patients are at risk of prolonged drug retention in their system due to diminished renal function; hence dosage and intervals should be adjusted alongside ensuring adequate hydration. In cases of overdose, severe symptoms such as coma, seizures, and confusion may occur, and renal failure could develop, meaning immediate medical attention should be sought. In instances of drug overdose, measuring blood concentration may be necessary, and treatment such as hemodialysis might be required if indicated. Administering high doses could have potential genetic effects or impact reproductive function; however, such effects have not been reported within the normal dosage range.

Side effects

  • Anaphylactic shock
  • anaphylaxis-like reactions
  • hypotension
  • shortness of breath
  • chest tightness
  • photosensitivity reactions
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 118 more
  • urticaria-like erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • forgetfulness
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • renal failure
  • crystalluria
  • increased BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • red blood cell casts in urine
  • pyuria
  • leukoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • agranulocytosis
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • upper abdominal pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • lethargy
  • general malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • shortness of breath
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disturbances
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • increased total cholesterol
  • elevated triglycerides
  • increased serum potassium
  • decreased serum albumin
  • anxiety
  • coma
  • seizures
  • drowsiness
  • confusion
  • hallucinations
  • agitation
  • seizure disorders
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness of the medication over time.

Appearance and packaging

Appearance

Light blue round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.